Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

c-erbB-3 protein expression in ovarian tumours

B J Simpson1, J Weatherill, E P Miller

  • 1ICRF Medical Oncology Unit, Western General Hospitals NHS Trust, Edinburgh, UK.

British Journal of Cancer
|April 1, 1995
PubMed
Summary

The c-erbB-3 protein is commonly found in ovarian tumors, with higher expression in borderline and early-stage malignant types. This suggests its potential role in ovarian cancer progression.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Implantable biosensors and their contribution to the future of precision medicine.

Veterinary journal (London, England : 1997)·2018
Same author

Chemotherapy-induced dynamic gene expression changes in vivo are prognostic in ovarian cancer.

British journal of cancer·2014
Same author

Defining the molecular response to trastuzumab, pertuzumab and combination therapy in ovarian cancer.

British journal of cancer·2012
Same author

Growth-control of human ovarian-carcinoma cells by insulin-like growth-factors.

Oncology reports·2011
Same author

Risk factors for necrotizing enterocolitis totalis: a case-control study.

Journal of perinatology : official journal of the California Perinatal Association·2011
Same author

Ovarian cancer models : technical review.

Methods in molecular medicine·2011

Area of Science:

  • Oncology
  • Molecular Biology
  • Immunohistochemistry

Background:

  • The c-erbB-3 protein is a member of the epidermal growth factor receptor family.
  • Its role in ovarian cancer is not fully understood.
  • Investigating c-erbB-3 expression can provide insights into ovarian tumor development.

Purpose of the Study:

  • To investigate the expression of c-erbB-3 protein in various human ovarian tumors.
  • To correlate c-erbB-3 expression levels with tumor characteristics and clinical parameters.

Main Methods:

  • Utilized a monoclonal antibody (RTJ1) for immunohistochemical staining of 73 ovarian tumor samples.
  • Graded staining intensity as negative, weak, moderate, or strong.
  • Analyzed expression patterns in relation to tumor type (benign, borderline, malignant), stage, and other clinical factors.

Related Experiment Videos

Main Results:

  • 85% of all ovarian tumors examined showed positive c-erbB-3 expression.
  • Positivity was high across benign (61%), borderline (100%), and malignant (89%) tumors, but significantly lower in benign compared to malignant (P=0.03).
  • Intense c-erbB-3 staining was more prevalent in borderline tumors than malignant ones (P=0.002) and in early-stage (I/II) versus late-stage (III/IV) malignant tumors (P=0.04).

Conclusions:

  • c-erbB-3 protein is frequently expressed in benign and malignant ovarian tumors.
  • Overexpression of c-erbB-3 is more common in borderline and early-stage invasive ovarian lesions.
  • These findings suggest a potential role for c-erbB-3 in the progression of ovarian tumors.